ACCESSION: MSBNK-SMB_Measured-HSA032P0422003
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'HC15-pos_7116': {'bp': 1518.0, 'sum': 2180.0}, 'HC20-pos_7389': {'bp': 1224.0, 'sum': 1987.0}, 'RA6-pos_7114': {'bp': 854.0, 'sum': 1516.0}, 'RA10-pos_7248': {'bp': 682.0, 'sum': 1548.0}, 'HC24-pos_7002': {'bp': 609.0, 'sum': 1068.0}, 'HC9-pos_7251': {'bp': 549.0, 'sum': 957.0}, 'RA7-pos_7104': {'bp': 549.0, 'sum': 1110.0}, 'HC21-pos_7038': {'bp': 383.0, 'sum': 791.0}, 'HC24-pos_7093': {'bp': 342.0, 'sum': 699.0}, 'RA17-pos_7354': {'bp': 253.0, 'sum': 406.0}, 'RA9-pos_6894': {'bp': 203.0, 'sum': 254.0}}
COMMENT: RETENTION_TIME_STDEV 0.039
COMMENT: PRECURSOR_M/Z_RAW 422.249106
COMMENT: PRECURSOR_M/Z_STDEV 0.001107
COMMENT: PRECURSOR_IN_MS1 mz 422.251472; int 118.931; delta(ppm) 13.190042
COMMENT: PROPOSED_CHARGE_STATE +1; mz 423.254388; int 32.721; cor 0.728
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+Na; M+K; mz 438.225482; int 17.852; cor 0.867
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 12.608; C22H36N3O3P; [M+H]+; delta(ppm) -12.607891
COMMENT: PROPOSED_MF SevenGoldenRules 8.686; C24H31N5O2; [M+H]+; delta(ppm) -8.686175
COMMENT: PROPOSED_MF SevenGoldenRules 6.979; C15H41N3O6P2; [M+H]+; delta(ppm) -6.979326
COMMENT: PROPOSED_MF SevenGoldenRules 5.512; C23H35NO6; [M+H]+; delta(ppm) -5.512243
COMMENT: PROPOSED_MF SevenGoldenRules 3.058; C17H36N5O5P; [M+H]+; delta(ppm) -3.057609
COMMENT: PROPOSED_MF SevenGoldenRules 0.116; C16H40NO9P; [M+H]+; delta(ppm) 0.116322
COMMENT: PROPOSED_MF SevenGoldenRules 4.038; C18H35N3O8; [M+H]+; delta(ppm) 4.038039
COMMENT: PROPOSED_MF SevenGoldenRules 6.963; C22H37N3OP2; [M+H]+; delta(ppm) 6.962709
COMMENT: PROPOSED_MF SevenGoldenRules 10.884; C24H32N5P; [M+H]+; delta(ppm) 10.884425
COMMENT: PROPOSED_MF SevenGoldenRules 13.588; C13H35N5O10; [M+H]+; delta(ppm) 13.588320
COMMENT: PROPOSED_MF SevenGoldenRules 14.058; C23H36NO4P; [M+H]+; delta(ppm) 14.058357
COMMENT: PROPOSED_MF SevenGoldenRules 14.757; C19H39N5P2; [M+Na]+; delta(ppm) -14.757221
COMMENT: PROPOSED_MF SevenGoldenRules 13.209; C27H33N3; [M+Na]+; delta(ppm) -13.209366
COMMENT: PROPOSED_MF SevenGoldenRules 11.409; C18H43NO4P2; [M+Na]+; delta(ppm) -11.408544
COMMENT: PROPOSED_MF SevenGoldenRules 7.271; C20H38N3O3P; [M+Na]+; delta(ppm) -7.270912
COMMENT: PROPOSED_MF SevenGoldenRules 3.133; C22H33N5O2; [M+Na]+; delta(ppm) -3.133280
COMMENT: PROPOSED_MF SevenGoldenRules 0.215; C21H37NO6; [M+Na]+; delta(ppm) 0.215397
COMMENT: PROPOSED_MF SevenGoldenRules 2.805; C15H38N5O5P; [M+Na]+; delta(ppm) 2.805174
COMMENT: PROPOSED_MF SevenGoldenRules 10.291; C16H37N3O8; [M+Na]+; delta(ppm) 10.291483
COMMENT: PROPOSED_MF SevenGoldenRules 13.377; C20H39N3OP2; [M+Na]+; delta(ppm) 13.377175
COMMENT: PROPOSED_MF SevenGoldenRules 14.925; C28H33NO; [M+Na]+; delta(ppm) 14.925030
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; UBRKDAVQCKZSPO-UHFFFAOYSA-N; C24H31N5O2; 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro- [CAS]
COMMENT: CONFIDENCE Level 5: Exact mass of interest 422.251392; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 7.536
MS$FOCUSED_ION: PRECURSOR_M/Z 422.251392
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-0001900000-64b1d3a3ae36a2a32bf6
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  376.2493480 175.6994 ? 376.251452 24.2552 74.57 0.4375 11
  422.2516495 999.0000 ? 422.254854 9.3736 0.00 1.0000 11
  422.3260018 128.2915 ? 422.329208 24.9689 111.77 -0.3118 9
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  376.249348 175.70 175
  422.251650 999.00 999
  422.326002 128.29 128
//
